Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. April 2023 07:00 ET | Quelle: FibroGen, Inc.

FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-2, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis

- 372 IPF Patients Enrolled -- Topline Data Anticipated Mid-2024 - SAN FRANCISCO, April 03, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the completion of patient...
30. September 2022 09:16 ET | Quelle: NextGen Prospect

NextGen Prospect Has Launched a Strategic Partnership With PFF

FAIRPORT, N.Y., Sept. 30, 2022 (GLOBE NEWSWIRE) -- NextGen Prospect, a cutting-edge sports data visualization and roster management solution, has partnered with PFF to provide stakeholders across...
29. September 2022 09:00 ET | Quelle: NextGen Prospect

NextGen Prospect Launches Strategic Partnership With PFF

FAIRPORT, N.Y., Sept. 29, 2022 (GLOBE NEWSWIRE) -- NextGen Prospect, a cutting-edge sports data visualization and roster management solution, has partnered with PFF to provide stakeholders across...